Novel hemiasterlin derivative and use thereof
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Natural hemiasterlin, derived from marine sponges, exhibits significant anticancer activity but raises safety concerns.
Innovation Solution
Development of novel hemiasterlin derivatives, including compounds of Chemical Formula 1 and their isomers, pharmaceutically acceptable salts, and solvates, conjugated with carriers such as antibodies to target specific cancer cells, forming drug-linker or carrier-drug conjugates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If natural hemiasterlin is used as an anticancer agent, then significant anticancer activity is achieved, but safety issues arise
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of natural hemiasterlin through substitution at specific positions (R1-R6 groups) to create derivatives with improved safety profiles while maintaining anticancer activity. This involves changing physical and chemical parameters of the molecule to reduce harmful effects.
Solution Approach 2:
The patent creates composite structures by conjugating hemiasterlin derivatives with carrier molecules (such as antibodies) to form drug-carrier conjugates. This composite approach allows the active drug component to be delivered more selectively to cancer cells, improving safety while maintaining efficacy.
2Object-affected harmful factors
If hemiasterlin derivatives are developed to improve safety, then safety profile is improved, but structural complexity increases
Solution Approach 1:
The patent applies local quality by making specific localized modifications to the hemiasterlin molecule at particular positions (R1-R6 substitution patterns) rather than comprehensive structural changes. This allows safety improvement through targeted modifications while minimizing overall structural complexity increases.
Data Source
Figure 1~2
AI summary
The present invention provides a novel hemiasterlin derivative, a preparation method therefor, and a use thereof. In the present invention, an anticancer effect is confirmed using a novel hemiasterlin derivative with improved stability.